These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26149526)

  • 1. Summary and Conclusions.
    Bakris G
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S23. PubMed ID: 26149526
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient Cases: 1. A Patient with Apparent Compliance.
    Sarafidis PA
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S15-8. PubMed ID: 26173982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension, June 13-16, 2014 Athens, Greece. Introduction.
    Redon J
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S3-4. PubMed ID: 25929685
    [No Abstract]   [Full Text] [Related]  

  • 4. Achieving Goal Blood Pressure.
    Laurent S
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S5-9. PubMed ID: 26002423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence and resistant hypertension.
    Hyman DJ; Pavlik V
    J Hum Hypertens; 2015 Apr; 29(4):213-8. PubMed ID: 25209307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A global approach to hypertension.
    van den Meiracker AH
    EuroIntervention; 2013 May; 9 Suppl R():R16-20. PubMed ID: 23732150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?].
    Dechend R; Derer W; Müller DN
    MMW Fortschr Med; 2009 Nov; 151(45):46-7. PubMed ID: 19960726
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing 'resistance': is adherence a target for treatment?
    Burnier M
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):439-43. PubMed ID: 25036746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension.
    Volpe M
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S1. PubMed ID: 26153400
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment: drug therapy of hypertension.
    Elliott WJ
    J Am Soc Hypertens; 2015 Mar; 9(3):239-41; quiz 242-3. PubMed ID: 25795551
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should Know.
    Volpe M; Gallo G; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):1-8. PubMed ID: 30604199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.
    Smith SM; Gurka MJ; Winterstein AG; Handberg E; Pepine CJ; Cooper-DeHoff RM
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005979. PubMed ID: 32008359
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing Treatment-Resistant Patients.
    Schmieder RE
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S11-3. PubMed ID: 26025221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Approaches are Much Needed for "Real World" Management of Hypertension in the Era of "Hypertension Paradox".
    Kario K
    Curr Hypertens Rev; 2018; 14(1):2-5. PubMed ID: 29943699
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension Treatment ACCORDing to SPRINT.
    Campos K; Sheth S; Coulter SA
    Tex Heart Inst J; 2016 Aug; 43(4):324-7. PubMed ID: 27547143
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in Three Nonadherent Patients.
    Šíma M; Slanař O
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):125. PubMed ID: 30531438
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.
    Bangalore S; Ley L
    Expert Opin Pharmacother; 2012 Feb; 13(3):345-55. PubMed ID: 22220825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.